FinnCap Reiterates Corporate Rating for Constellation Healthcare Tech Inc (CHT)

Constellation Healthcare Tech Inc (LON:CHT)‘s stock had its “corporate” rating reissued by FinnCap in a report issued on Friday. They presently have a GBX 310 ($4.05) price target on the stock. FinnCap’s target price would indicate a potential upside of 83.43% from the company’s previous close.

Shares of Constellation Healthcare Tech (LON:CHT) opened at 169.00 on Friday. The firm’s market cap is GBX 141.67 million. Constellation Healthcare Tech has a 1-year low of GBX 126.00 and a 1-year high of GBX 185.00. The stock’s 50 day moving average is GBX 153.94 and its 200-day moving average is GBX 144.54.

Constellation Healthcare Tech Company Profile

Constellation Healthcare Technologies, Inc is a healthcare services organization providing outsourced business services to the physician market. The Company operates through three operating segments: Revenue Cycle Management (RCM), Practice Management (PM) and Group Purchasing Organization (GPO). The RCM segment offers medical billing and collections, practice management, and other related services to hospital-based and office-based physicians, allowing them to focus on patient care in specialties, such as pathology, anesthesiology, radiology, cardiology, family practice, internal medicine, orthopedics, neurology and emergency medicine.

Receive News & Ratings for Constellation Healthcare Tech Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Constellation Healthcare Tech Inc and related companies with's FREE daily email newsletter.

Leave a Reply

© 2006-2016 Mideast Time.